In patients with GBM, it has been observed that an enhanced expression of IFN-gamma has been associated with better patient outcomes, while the IL-6 axis specifically has been associated with both increased tumor growth and expression of an M2-like myeloid phenotype (32, 122, 127). This evidence concerns the gene IFNG and neoplasm.